Pre-Hospital Zone 1 Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Injured Patients With Exsanguinating Sub-diaphragmatic Haemorrhage

Emergencies Clinical Trial

— P-PRO  

Official title:

Pre-Hospital Zone 1 Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Injured Patients With Exsanguinating Sub-diaphragmatic Haemorrhage (P-PRO-Study)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04145271
• Other study ID #: 271728
• Status: Completed
• Start date: June 27, 2020
• Est. completion date: March 31, 2022

Study information

• Verified date: May 2022
• Source: Barts & The London NHS Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

It is unknown whether this evolved strategy (Pre-Hospital Zone I P-REBOA) is feasible and with an acceptable safety profile. This study will address this question, therefore informing the design of a prospective multicentre exploratory cohort study followed by a pilot/feasibility multicenter RCT (IDEAL 2B). The IDEAL Framework is an internationally recognised standard, that describes the stages through which interventional therapy innovation normally passes, the characteristics of each stage and the study design types recommended for each

Description:

Haemorrhage (bleeding) is the most common cause of preventable death after injury and is responsible for approximately one-third of trauma deaths (of which between 16-29% of such deaths are thought to be preventable).

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is a minimally invasive damage control procedure for life-threatening abdominal and/or pelvic haemorrhage. It involves temporary occlusion of the aorta with an endovascular balloon, providing proximal control to the site of vascular injury whilst supporting cerebral and myocardial perfusion.

Emergency Department (ED) use of REBOA appears to be feasible and associated with improved outcomes. However, bleeding trauma patients die quickly and it's evident that the peak death rate from haemorrhage occurs within 30 minutes of injury. This is well before the majority of patients can reach hospital, it's therefore likely this resuscitation strategy may have greatest benefit for patients when used in the pre-hospital environment.

We have demonstrated that Pre-Hospital Zone III REBOA (distal aortic occlusion) for exsanguinating pelvic haemorrhage is a feasible resuscitation strategy that significantly improves blood pressure and may reduce the risk of hypovolaemic cardiac arrest and early death due to exsanguination.

To evolve this resuscitation strategy, it is important to establish whether it can be delivered in patients with more proximal haemorrhage in the abdomen (Zone I REBOA). However, this development may be associated with increased risk of harm due to the visceral ischaemia that is created. The use of a technique called Partial REBOA (P-REBOA) may offer a solution by mitigating the ischaemia/reperfusion injury created.

It is unknown whether this evolved strategy (Zone I P-REBOA) is feasible in the pre-hospital setting. This study therefore aims to establish via an Observational Cohort of eight adult trauma patients whether Zone I P-REBOA can be achieved in pre-hospital resuscitation of adult trauma patients with exsanguiunating sub-diaphragmatic haemorrhage at risk of imminent hypovolaemic cardiac arrest or recent hypovolaemic cardiac arrest.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: March 31, 2022
• Est. primary completion date: March 31, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria -

• Adult trauma patients (aged, or believed to be aged 16 years or older) attended by LAA;

• assessed to have exsanguinating sub-diaphragmatic haemorrhage and imminent risk of hypovolaemic cardiac arrest, or recent hypovolaemic cardiac arrest;

• which is thought to be amenable to treatment with Zone I REBOA;

• and an attempt is made at femoral arterial access (percutaneous access or open surgical approach to insert 8Fr REBOA access sheath)

Exclusion Criteria -

• Age < 16 years

• Injuries deemed clinically unsurvivable

• Known or visible advanced pregnancy

Related Conditions & MeSH terms

• Emergencies
• Hemorrhage
• Multiple Trauma
• Trauma Injury
• Trauma, Multiple
• Wounds and Injuries

Intervention

Device:
• Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)
Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is a minimally invasive damage control procedure for life-threatening abdominal and/or pelvic haemorrhage. It involves temporary occlusion of the aorta with an endovascular balloon, providing proximal control to the site of vascular injury whilst supporting cerebral and myocardial perfusion

Locations

Country	Name	City	State
United Kingdom	London HEMS	London
United Kingdom	Royal London Hospital	London
United Kingdom	St. Georges Hospital	London
United Kingdom	St.Marys Hospital	London

Sponsors (1)

Lead Sponsor	Collaborator
Barts & The London NHS Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Zone 1 REBOA	The proportion of patients where Pre-Hospital Zone 1 REBOA is achieved, defined as: Balloon insertion depth between 35 - 55 cm; Proximal arterial blood pressure transduced; Balloon inflation	1 day
Primary	Partial REBOA (P-REBOA)	The proportion of Pre-Hospital Zone 1 REBOA patients where P-REBOA is achieved, defined as: Evidence of an increase in distal mean arterial pressure (MAP) of at least 5mm - 10mmHg above post inflation baseline; and/or a return of distal pulsatility; or distal pulsatility never absent post initial balloon inflation.	1 day
Secondary	• Incidence of Zone I balloon positioning in the ED	On routinely performed plain film chest X-Ray. Defined as balloon positioned between T4 - L1 and/or distal to carina, proximal to diaphragm) or on CT.	1 Days
Secondary	• Incidence of pre-hospital balloon migration	(>2cm from the recorded insertion depth, reported by the pre-hospital clinical team	1 Day
Secondary	• Incidence of balloon repositioning (proximal or distal) pre or in-hospital.	Repostioned in aorta for clinical reason	1 Day
Secondary	• Method of achieving Partial REBOA	Balloon deflation, spontaneous, or straight to P-REBOA.	1 Day
Secondary	• Incidence of failed femoral arterial access	Inability to successfully cannulate the CFA percutaneously or via an open approach.	1 Day
Secondary	• Time elapsed from balloon inflation to the institution or recognition of P-REBOA.	Temporal	1 Day
Secondary	• Incidence of balloon reinflation or the requirement for additional balloon volume, post institution or recognition of P-REBOA.	For clinical reason.	1 Day
Secondary	• Total duration of REBOA (inflation to final deflation).	Temporal	1 Day
Secondary	• Systolic blood pressure response to institution of REBOA	Physiological	1 day
Secondary	• Incidence of pre-hospital cardiac arrest	Pre and post REBOA, absent carotid or central pulse.	1 day
Secondary	• Incidence of pre-hospital, ED, or operating theatre resuscitative thoracotomy (RT).	RT	1 Day
Secondary	• Mortality rate - Pre-hospital, one hour, 3 hours, 24 hours, 30 and 90 days.	Mortality	90 days.
Secondary	• Causes of death (in-hospital and pre-hospital) of patients who received Pre-Hospital REBOA or did not following a failed attempt.	This will be determined by the SMG following review of all the routinely available clinical information (CT scan results, operative findings and post-mortem findings).	1 year
Secondary	• Survival to hospital discharge.	Survival	90 Days
Secondary	• Length of critical care and hospital stay.	Temporal	90 Days
Secondary	• Incidence of all adverse events related to patient injury, resulting critical illness and treatment as well as femoral cannulation, REBOA catheter insertion and/or the anticipated effects of aortic occlusion:	Distal arterial thrombus formation requiring intervention; Vascular trauma (related to primary injury or intervention); Surgical repair femoral arterial cannulation site (patch angioplasty); Arterial bypass surgery; Cannulation site infection requiring surgical intervention; Extremity ischaemia requiring fasciotomies; Amputation (primary); Amputation (secondary); Acute renal failure (KDIGO Criteria Stage 3); Requirement for renal replacement therapy (RRT); Acute intestinal ischaemia (Evidence of gut necrosis at laparotomy or findings on CT scanning consistent with gut ischaemia in the context of elevated blood lactate).; Multiple Organ Dysfunction Syndrome (MODS, 2 or more organ system failure) including severity of MODS (Sequential Organ Failure Assessment, SOFA Score).	90 Days